INVESTOR RIGHTS AGREEMENT by and between JAGUAR ANIMAL HEALTH, INC. and NANTUCKET INVESTMENTS LIMITED Dated as of March 31, 2017Investor Rights Agreement • March 31st, 2017 • Jaguar Animal Health, Inc. • Pharmaceutical preparations • Delaware
This INVESTOR RIGHTS AGREEMENT (this “Agreement”), dated as of March 31, 2017 (and effective as set forth in Section 5.11 of this Agreement), is made and entered into by and among Jaguar Animal Health, Inc., a Delaware corporation (the “Company” or “Jaguar”), and Nantucket Investments Limited, a company organized under the laws of Guernsey (“Nantucket”). The Company and Nantucket are referred to individually as a “Party” and collectively as the “Parties.”
AGREEMENT AND PLAN OF MERGERAgreement and Plan of Merger • March 31st, 2017 • Jaguar Animal Health, Inc. • Pharmaceutical preparations • Delaware
This AGREEMENT AND PLAN OF MERGER (this "Agreement") is made and entered into as of March 31, 2017, by and among Jaguar Animal Health, Inc., a Delaware corporation ("Parent"), Napo Acquisition Corporation, a Delaware corporation ("Merger Sub"), Napo Pharmaceuticals, Inc., a Delaware corporation ("Company"), and Gregory Stock, the Company Representative. Certain capitalized terms that are used in this Agreement are defined in Article IX. Appendix I provides an index to certain capitalized terms that are defined in other provisions of this Agreement.
